NOT KNOWN FACTS ABOUT LP-PLA2-IN-1

Contraindicated (1)bortezomib will boost the level or outcome of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Potent or average CYP2C19 inhibitors may possibly enhance mavacamten systemic exposure, causing coronary heart failure on account of systolic dysfunction.Important: The drug info on this website page is mean

Pyrimidine nucleoside analogues, which include BVDU and BVaraU, is often degraded by pyrimidine catabolic enzymes (such as uridine phosphorylase or thymidine phosphorylase (TPase) bringing about their cost-free foundation metabolites without having antiviral action. BVDU can not be administered along with 5-flurouracil or its prodrug capecitabine b